Regen BioPharma Inc. Their goal is to rapidly advance novel technologies through pre-clinical and Phase I/II clinical trials. Currently, Regen BioPharma Inc.

Additionally, Regen BioPharma Inc. With a dedicated team of experts in investment banking, venture capital, basic science, drug development, medical practice, and commercialization, Regen BioPharma Inc. They have multiple technologies targeting various types of cancer and disorders of the immune system